BRAC University Institutional Repository

Vaccination against Helicobacter pylori – a review

Show simple item record

dc.contributor.advisor Jahan, Nazneen
dc.contributor.author Ferdous, Sadia Rehnuma
dc.date.accessioned 2018-11-08T07:54:08Z
dc.date.available 2018-11-08T07:54:08Z
dc.date.copyright 2018
dc.date.issued 2018
dc.identifier.other ID 13126005
dc.identifier.uri http://hdl.handle.net/10361/10828
dc.description This thesis is submitted in partial fulfilment of the requirements for the degree of Bachelor of Science in Microbiology, 2018. en_US
dc.description Catalogued from PDF version of thesis report.
dc.description Includes bibliographical references (page 32-43).
dc.description.abstract Since the colonization of H. pylori has sweeping wellbeing results, it speaks to a huge general wellbeing challenge. Current medicines utilize numerous anti-infection agents in blend with corrosive concealment pharmaceuticals to annihilate it. Because of an expansion in antimicrobial obstruction, it is currently harder to dispose of, and the improvement of an antibody as an elective treatment is of expanded intrigue. In this way, H. pylori is the significant reason for gastric malignancy around the world. It has been named a class ⅰ cancer-causing agent by the World Health Organization. Since its revelation in the mid-eighties by Warren and Marshall, inquire about has been centered on the examination of H. pylori science, have pathogen communication, anticipation and treatment. Despite the fact that H. pylori incites a solid humoral and nearby cell invulnerable reaction, the pathogen isn't cleared and sets up a ceaseless contamination after experiences in adolescence. The capacity to colonize the stomach is interceded by a few harmfulness factors that change the host condition, elevate grip to the epithelium, impact the gastric aggravation and prompt safe avoidance. H. pylori can be annihilated by anti-toxin treatment in mix with a proton-pump inhibitor, yet viability is diminishing. Current treatments are costly, have symptoms and add to expanding anti-toxin opposition, underlining the requirement for novel therapeutics. That is the reason immunization advancement against H. pylori remains a focal point of research. Advancement is made yet is incremental. There is requirement for a still better comprehension of the defensive instrument and for enhancing adequacy, sooner rather than later. en_US
dc.description.statementofresponsibility Sadia Rehnuma Ferdous
dc.format.extent 43 pages
dc.language.iso en en_US
dc.publisher BRAC University en_US
dc.rights BRAC University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subject Helicobacter pylori en_US
dc.subject.lcsh Helicobacter pylori infections.
dc.title Vaccination against Helicobacter pylori – a review en_US
dc.type Thesis en_US
dc.contributor.department Department of Mathematics and Natural Sciences, BRAC University
dc.description.degree B. Microbiology


Files in this item

This item appears in the following Collection(s)

Show simple item record

Policy Guidelines

Search BRACU Repository


Advanced Search

Browse

My Account

Statistics